Generally, if there is no significant bone marrow suppression, it takes effect in one week with Tebteo. Terbio is recombinant human thrombopoietin injection for the treatment of thrombocytopenia due to chemotherapy for solid tumors, or in patients with platelets below 50 x 10^9/L and in whom platelet elevation therapy is deemed necessary by the physician. In the case of chemotherapy for malignant solid tumors where the anticipated dose of chemotherapeutic agents may cause thrombocytopenia and induce bleeding and platelet elevation is required, TBio may be administered subcutaneously 6-24 hours after the end of chemotherapy. Monitor platelets during administration and discontinue if platelet count returns to 100×10^9/L, or if absolute platelet value rises by 50×10^9/L.